A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject

Completed · Phase 1 · Has a placebo group

Conditions studied: Immunoscience

In brief

The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects

Key facts

Study ID

NCT03196557

Run by

Bristol-Myers Squibb

People needed

24

Starts

2008-03-31

Expected to finish

2008-05-05

Last updated by the study team

2019-12-06

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy male subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
• Body Mass Index (BMI) of 18 to 30 kilogram / square meter (kg/m2), inclusive
• Signed informed consent

You may not qualify if…

• Women
• Any significant acute or chronic medical illness
• Current or recent (within 3 months) gastrointestinal disease including peptic ulcer
• Other protocol inclusion/exclusion criteria may apply

Where it is running

• Ppd Development — Austin, Texas, United States
• Local Institution — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.